Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy

Authors
Rubio-Gozalbo, ME van Waardenburg, DA Forget, PP Spaapen, LJM Verrips, A Vroomen, PCAJ
Citation
Me. Rubio-gozalbo et al., Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy, J INH MET D, 24(5), 2001, pp. 605-606
Citations number
3
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF INHERITED METABOLIC DISEASE
ISSN journal
01418955 → ACNP
Volume
24
Issue
5
Year of publication
2001
Pages
605 - 606
Database
ISI
SICI code
0141-8955(200110)24:5<605:NMSDZT>2.0.ZU;2-P
Abstract
An 8 year-old boy with X-ALD under treatment with sinavastatin developed a severe adverse reaction when the dose of his other medication, zuclopenthix ol was increased. Both drugs were withdrawn after a diagnosis of neurolepti c malignant syndrome was made.